Literature DB >> 88202

Pharmacokinetics of halogenated hydrocarbons.

P M Bungay, R L Dedrick, H B Matthews.   

Abstract

Pharmacokinetic modeling is being applied to chemicals posing health hazards because of their presence as contaminants in our environment. This paper presents a rationale for constructing mathematical models based on anatomic and physiological principles. Pharmacokinetic investigations incorporating such models are illustrated for two halogenated hydrocarbons that exhibit different patterns of disposition in the rat: 2,2',4,4',5,5'-hexachlorobiphenyl and Kepone. The models permit interspecies comparison and prediction of normal pharmacokinetic behavior and alterations induced by intervention measures. As an example a theoretical limit is predicted in the case of a treatment for Kepone poisoning involving oral administration of adsorbents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88202     DOI: 10.1111/j.1749-6632.1979.tb56607.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Bronchial responsiveness in an area of air pollution resulting from wire reclamation.

Authors:  J Y Wang; T R Hsiue; H I Chen
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

2.  Enteric transport of chlordecone (Kepone) in the rat.

Authors:  P M Bungay; R L Dedrick; H B Matthews
Journal:  J Pharmacokinet Biopharm       Date:  1981-06

3.  A physiological model for the pharmacokinetics of methylene chloride in B6C3F1 mice following i.v. administrations.

Authors:  M J Angelo; K B Bischoff; A B Pritchard; M A Presser
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

4.  Residential and recreational acquisition of possible estuary-associated syndrome: a new approach to successful diagnosis and treatment.

Authors:  R C Shoemaker
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

5.  Possible estuary-associated syndrome: symptoms, vision, and treatment.

Authors:  R C Shoemaker; H K Hudnell
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.